Clinical advances in hematology & oncology : H&O.
|
The Mechanism of Action of Regorafenib in Colorectal Cancer: Q&A.
|
Grothey A1, Prager G2, Yoshino T3 |
 Author information
1West Cancer Center and Research Institute, OneOncology, Germantown, Tennessee.
2Department of Medicine I, Division of Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria.
3Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Japan; Kashiwa, Japan.
|
Publikations ID: 32720935
Quelle: öffnen
|